Clinical trials
Myocardial Infarction trials in Russia with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
6 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 6 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Meshalkin Research Institute of Pathology of Circulation | 2 |
| Center for Strategic Planning, of the Federal Medical and Biological Agency | 1 |
| Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 1 |
| Novosibirsk State Medical University | 1 |
| Ryazan State Medical University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myocardial Infarction | 6 |
| Atherosclerosis | 1 |
| Atrial Fibrillation | 1 |
| COVID-19 | 1 |
| Cardiovascular Diseases | 1 |
| Coronary Artery Disease | 1 |
| Coronary Disease | 1 |
| Heart Failure | 1 |
| Ischemic Stroke | 1 |
| Pulmonary Embolism | 1 |
Trials
Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.